CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 217 of 2
Non-Antibody Products
Page 217 of 2,593
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Avacopan | A C5a1 receptor antagonist (IC50 = 0.1 nM); selective for C5a1 over the C5… | 10 mg | 36639-10 | More Info |
| Avacopan | A C5a1 receptor antagonist (IC50 = 0.1 nM); selective for C5a1 over the C5… | 25 mg | 36639-25 | More Info |
| Avacopan | A C5a1 receptor antagonist (IC50 = 0.1 nM); selective for C5a1 over the C5… | 5 mg | 36639-5 | More Info |
| Avagacestat | A potent, orally bioavailable inhibitor of γ-secretase that more pot… | 1 mg | 16711-1 | More Info |
| Avagacestat | A potent, orally bioavailable inhibitor of γ-secretase that more pot… | 10 mg | 16711-10 | More Info |
| Avagacestat | A potent, orally bioavailable inhibitor of γ-secretase that more pot… | 5 mg | 16711-5 | More Info |
| Avanafil | A potent and selective PDE5 inhibitor (IC50s = 2.2, 630, >5,000, and >5,00… | 1 g | 23024-1 | More Info |
| Avanafil | A potent and selective PDE5 inhibitor (IC50s = 2.2, 630, >5,000, and >5,00… | 100 mg | 23024-100 | More Info |
| Avanafil | A potent and selective PDE5 inhibitor (IC50s = 2.2, 630, >5,000, and >5,00… | 250 mg | 23024-250 | More Info |
| Avanafil | A potent and selective PDE5 inhibitor (IC50s = 2.2, 630, >5,000, and >5,00… | 500 mg | 23024-500 | More Info |
| Avanafil-13C-d3 | An internal standard for the quantification of avanafil by GC- or LC-MS | 1 mg | 31687-1 | More Info |
| Avanafil metabolite M16 | A major inactive metabolite of avanafil | 1 mg | 27844-1 | More Info |
| Avanafil metabolite M4 | An active metabolite of avanafil; M4 inhibits PDE5 with 18% of the potency… | 1 mg | 27843-1 | More Info |
| Avasimibe | An orally bioavailable inhibitor of ACAT (IC50s = 24 and 9.2 µM for… | 10 mg | 18129-10 | More Info |
| Avasimibe | An orally bioavailable inhibitor of ACAT (IC50s = 24 and 9.2 µM for… | 25 mg | 18129-25 | More Info |
| Avasimibe | An orally bioavailable inhibitor of ACAT (IC50s = 24 and 9.2 µM for… | 5 mg | 18129-5 | More Info |
| Avasimibe | An orally bioavailable inhibitor of ACAT (IC50s = 24 and 9.2 µM for… | 50 mg | 18129-50 | More Info |
| Avatrombopag | A thrombopoietin receptor agonist; induces proliferation of Ba / F3 cells… | 10 mg | 26535-10 | More Info |
| Avatrombopag | A thrombopoietin receptor agonist; induces proliferation of Ba / F3 cells… | 25 mg | 26535-25 | More Info |
| Avatrombopag | A thrombopoietin receptor agonist; induces proliferation of Ba / F3 cells… | 5 mg | 26535-5 | More Info |
| Avatrombopag | A thrombopoietin receptor agonist; induces proliferation of Ba / F3 cells… | 50 mg | 26535-50 | More Info |
| AVE-0991 | A Mas receptor agonist; binds to the Mas receptor in bovine aortic endothe… | 1 mg | 37837-1 | More Info |
| AVE-0991 | A Mas receptor agonist; binds to the Mas receptor in bovine aortic endothe… | 10 mg | 37837-10 | More Info |
| AVE-0991 | A Mas receptor agonist; binds to the Mas receptor in bovine aortic endothe… | 25 mg | 37837-25 | More Info |
| AVE-0991 | A Mas receptor agonist; binds to the Mas receptor in bovine aortic endothe… | 5 mg | 37837-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile